Detalles de la búsqueda
1.
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.
J Infect Dis
; 218(3): 378-387, 2018 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29617814
2.
Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control.
J Biomed Sci
; 25(1): 7, 2018 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29374458
3.
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.
J Transl Med
; 10: 156, 2012 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22862954
4.
Generation of highly activated, antigen-specific tumor-infiltrating CD8+ T cells induced by a novel T cell-targeted immunotherapy.
Oncoimmunology
; 9(1): 1782574, 2020 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32923145
5.
Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein.
Hum Vaccin Immunother
; 16(9): 2007-2017, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32530723
6.
Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics.
Front Immunol
; 11: 264, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32210956
7.
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challenge.
NPJ Vaccines
; 4: 6, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30774997
8.
Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax.
J Transl Med
; 5: 20, 2007 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-17451606
9.
Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.
PLoS One
; 12(6): e0180073, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28662082
10.
Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide.
J Immunother Cancer
; 4: 68, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27777777
11.
Using MRI to evaluate and predict therapeutic success from depot-based cancer vaccines.
Mol Ther Methods Clin Dev
; 2: 15048, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26730395
12.
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.
Oncoimmunology
; 4(8): e1026529, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26405584
13.
Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.
Vaccine
; 32(51): 6956-6962, 2014 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25444822
14.
Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response.
Oncoimmunology
; 3(8): e953407, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25960932
15.
Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.
Cancers (Basel)
; 3(3): 3114-42, 2011 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24212948
16.
A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery.
Vaccine
; 28(38): 6176-82, 2010 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-20656034
17.
A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.
J Immunother
; 33(3): 250-61, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20445345
Resultados
1 -
17
de 17
1
Próxima >
>>